MOU
NRDC Transfers Mosquito Control Larvicidal Formulation Technology to Som Phyto Pharma India Ltd
New Delhi: Dr. H. Purushotham, CMD, National Research Development Corporation, informed that NRDC and M/s Som Phyto Pharma India Ltd, Hyderabad, have entered into License Agreements for commercialization of Mosquito Larvicidal formulation of Bacillus Thuringiensis Var. Israelensis, an aqueous suspension for killing mosquito at the larval stage. The innovative technology was developed by VCRC, Pondicherry, a laboratory under ICMR, Ministry of Health.
Mosquito Larvicidal formulation of Bacillus Thuringiensis Var. Israelensis is proven bio-control agents and has come to be recognized as one of the prime candidates against the larvae of several mosquito species such as Aedes, Anopheles, Culex etc. Bacillus thuringiensis var. israelensis is extremely safe to associate aquatic organisms like copepods, beetles, fishes etc. and beneficial insects like honeybees and silkworms.
Extensive field trials as per CIB guidelines have been conducted by the laboratory. The residual activity of the formulation was assessed as per the protocol described by WHO (2005). CIB has already given permanent registration under section 9 (3) of Central Insecticide Board and Registration Committee (CIB&RC) for production of the larvicide, which is mandatory.
NRDC has so far licensed this technology to 17 companies in India and contributing to Startup India and Make In India Programme of Government.
News Must Read
- NCL General Manager (Finance) D Sunil Kumar recommended for SECL Director (Finance)
- Bank of Maharashtra Q4 results, Net Profit increased by 44.95 percent to Rs 1,218 crore
- Axis Bank Overtakes Kotak Mahindra Bank to Become India's Fourth Most Valued Lender
- LIC cuts stakes in major PSU stocks
- SJVN CMD Geeta Kapur Inaugurates Construction Works at Sunni Dam Project in Himachal Pradesh
- PESB Selects R Veerabahu as Director (Finance) for Braithwaite & Co. Limited
- Grew Energy bags largest order of 200 MW Contract of SECI's Auction
- CPCL Reports 39% YoY Drop in Q4 Net Profit, Declares Rs 55 per Share Dividend
- SJVN Limited inaugurates India's first Multi-purpose Green Hydrogen Pilot Project
- KRDCL, RVNL JV emerges as the Lowest Bidder for Redevelopment of Thiruvananthapuram Central Railway Station